Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Minneapolis, Minnesota 55455


Purpose:

To investigate the potential benefit of providing passive immunity with hyperimmune anti-HIV human serum.


Criteria:

Inclusion Criteria Patients must have: - Proof of HIV infection. - Diagnosis of asymptomatic HIV infection or early AIDS related complex (ARC) with no zidovudine (AZT) or other anti-HIV therapy. OR a diagnosis of AIDS and = or > 3 months of AZT therapy. Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: - HIV-induced neurological disease. - IgA negative. Concurrent Medication: Excluded: - Immunomodulating agents. - Steroids. - Interferons. Patients with the following are excluded: - Active substance abuse. - Use of immunomodulating drugs such as steroids or interferons. - HIV-induced neurological disease. - IgA negative. Required with a diagnosis of AIDS: - = or > 3 months of zidovudine (AZT) therapy. Active substance abuse.


NCT ID:

NCT00002036


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Minneapolis, Minnesota 55455
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.